Chemoinformaics analysis of P-Mentha-1,4-Dien-8-Ol
| Molecular Weight | 152.237 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 6 |
| Exact Molecular Weight | 152.12 | nRing | 1 |
| Solubility: LogS | -2.154 | nHRing | 0 |
| Solubility: LogP | 2.5 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 1 | BPOL | 16.0513 |
| QED | 0.572 |
| Synth | 3.509 |
| Natural Product Likeliness | 2.039 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.333 |
| MDCK | 0.0000164 |
| BBB | 0.717 |
| PPB | 0.701706 |
| VDSS | 2.11 |
| FU | 0.311294 |
| CYP1A2-inh | 0.251 |
| CYP1A2-sub | 0.126 |
| CYP2c19-inh | 0.09 |
| CYP2c19-sub | 0.509 |
| CYP2c9-inh | 0.035 |
| CYP2c9-sub | 0.78 |
| CYP2d6-inh | 0.027 |
| CYP2d6-sub | 0.354 |
| CYP3a4-inh | 0.028 |
| CYP3a4-sub | 0.225 |
| CL | 8.678 |
| T12 | 0.672 |
| hERG | 0.002 |
| Ames | 0.005 |
| ROA | 0.025 |
| SkinSen | 0.343 |
| Carcinogencity | 0.964 |
| EI | 0.971 |
| Respiratory | 0.154 |
| NR-Aromatase | 0.017 |
| Antiviral | No |
| Prediction | 0.91533 |